Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Jul 1;15(7):923-925.
doi: 10.2215/CJN.07610520. Epub 2020 Jun 11.

ADPKD, Tolvaptan, and Nephrolithiasis Risk

Ewout J Hoorn  1 , Robert Zietse
Affiliations
Editorial

ADPKD, Tolvaptan, and Nephrolithiasis Risk

Ewout J Hoorn et al. Clin J Am Soc Nephrol. .
No abstract available

Keywords: Autosomal Dominant; Kidney Calculi; Polycystic Kidney; Tolvaptan; calcium; cyclic AMP; cystic kidney; hypercalciuria; kidney stones; kidney tubule; polycystic kidney disease; risk factors.

PubMed Disclaimer

Comment on

References

    1. Torres V, Erickson S, Smith L, Wilson D, Hattery R, Segura J: The association of nephrolithiasis and autosomal dominant polycystic kidney disease. Am J Kidney Dis 11: 318–325, 1988. - PubMed
    1. Nishiura J, Neves R, Eloi S, Cintra S, Ajzen S, Heilberg I: Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients. Clin J Am Soc Nephrol 4: 838–844, 2009. - PMC - PubMed
    1. Cheungpasitporn W, Erickson S, Rule A, Enders F, Lieske J: Short-term tolvaptan increases water intake and effectively decreases urinary calcium oxalate, calcium phosphate and uric acid supersaturations. J Urol 195: 1476–1481, 2016. - PMC - PubMed
    1. Tominaga N, Fernandez S, Mete M, Shara N, Verbalis J: Hyponatremia and the risk of kidney stones: A matched case-control study in a large U.S. Health system. PLoS One 13: e0203942, 2018. - PMC - PubMed
    1. Bargagli M, Dhayat NA, Anderegg M, Semmo M, Huynh-Do U, Vogt B, Ferraro PM, Fuster DG: Urinary lithogenic risk profile in ADPKD patients treated with tolvaptan. Clin J Am Soc Nephrol 15: 1007–1014, 2020 - PMC - PubMed

MeSH terms

Substances